RSCM
BLCM

Rock Springs Capital Management’s Bellicum Pharmaceuticals, Inc. BLCM Stock Holding History

Rock Springs Capital Management’s Portfolio BLCM Stock Details BLCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-3,500
Closed -$806K – 111
2014
Q4 		$806K Buy
+3,500
New +$751K 0.09% 93

Other funds holding BLCM

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Rock Springs Capital Management's BLCM Position: Q1 2015 in Review

Rock Springs Capital Management sold out of Bellicum Pharmaceuticals, Inc. (BLCM) in Q1 2015, closing a stake of 3,500 shares — an estimated $806K sold.

Rock Springs Capital Management first reported a position in BLCM in Q4 2014 and held it in 1 quarter. The position peaked at $806K in Q4 2014. 71 funds tracked by Wall St. Rank hold BLCM as of Q1 2015.

  • Rock Springs Capital Management reported no remaining Bellicum Pharmaceuticals, Inc. position as of Q1 2015 after selling out during the quarter.
  • Rock Springs Capital Management sold 3,500 Bellicum Pharmaceuticals, Inc. shares in Q1 2015, an estimated $806K.
  • Rock Springs Capital Management first reported a position in Bellicum Pharmaceuticals, Inc. in Q4 2014 and held it in 1 quarter.
  • Rock Springs Capital Management's Bellicum Pharmaceuticals, Inc. position peaked at $806K in Q4 2014.
  • 71 funds tracked by Wall St. Rank held Bellicum Pharmaceuticals, Inc. as of Q1 2015.

Based on Rock Springs Capital Management's 13F filing for Q1 2015, filed 15 May 2015.